InspireMD (NSPR) Operating Income Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.35% |
| Sep 30, 2025 | -42.84% |
| Jun 30, 2025 | -39.71% |
| Mar 31, 2025 | -41.49% |
| Dec 31, 2024 | 55.03% |
| Sep 30, 2024 | -33.48% |
| Jun 30, 2024 | -30.49% |
| Mar 31, 2024 | -18.82% |
| Dec 31, 2023 | -21.36% |
| Sep 30, 2023 | -23.30% |
| Jun 30, 2023 | -29.26% |
| Mar 31, 2023 | -17.54% |
| Dec 31, 2022 | -27.78% |
| Sep 30, 2022 | -17.20% |
| Jun 30, 2022 | -15.33% |
| Mar 31, 2022 | -13.29% |
| Dec 31, 2021 | -13.42% |
| Sep 30, 2021 | -18.05% |
| Jun 30, 2021 | -14.27% |
| Mar 31, 2021 | -10.30% |
| Dec 31, 2020 | -7.32% |
| Sep 30, 2020 | 8.44% |
| Jun 30, 2020 | 7.30% |
| Mar 31, 2019 | 10.78% |
| Sep 30, 2018 | 12.62% |
| Jun 30, 2018 | 18.96% |
| Mar 31, 2018 | 9.47% |
| Dec 31, 2017 | 19.80% |
| Sep 30, 2017 | 8.67% |
| Mar 31, 2017 | 5.12% |
| Dec 31, 2016 | 23.96% |
| Sep 30, 2016 | 3.95% |
| Jun 30, 2016 | 4.05% |
| Mar 31, 2016 | -11.65% |
| Dec 31, 2015 | -17.44% |
| Sep 30, 2015 | -36.61% |
| Jun 30, 2015 | -38.98% |